NO932731L - New isobutyl-substituted methanesulfonyl-quinolylmethoxy-phenyl-cycloalkyl-acetic acid amides - Google Patents

New isobutyl-substituted methanesulfonyl-quinolylmethoxy-phenyl-cycloalkyl-acetic acid amides

Info

Publication number
NO932731L
NO932731L NO932731A NO932731A NO932731L NO 932731 L NO932731 L NO 932731L NO 932731 A NO932731 A NO 932731A NO 932731 A NO932731 A NO 932731A NO 932731 L NO932731 L NO 932731L
Authority
NO
Norway
Prior art keywords
quinolylmethoxy
cycloalkyl
phenyl
acetic acid
acid amides
Prior art date
Application number
NO932731A
Other languages
Norwegian (no)
Other versions
NO179948C (en
NO932731D0 (en
NO179948B (en
Inventor
Siegfried Raddatz
Klaus-Helmut Mohrs
Michael Matzke
Romanis Fruchtmann
Reiner Mueller-Peddinghaus
Armin Hatzelmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO932731D0 publication Critical patent/NO932731D0/en
Publication of NO932731L publication Critical patent/NO932731L/en
Publication of NO179948B publication Critical patent/NO179948B/en
Publication of NO179948C publication Critical patent/NO179948C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO932731A 1992-08-12 1993-07-29 New isobutyl-substituted methanesulfonyl-quinolylmethoxyphenyl-cycloalkylacetic acid amides and their use NO179948C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226649A DE4226649A1 (en) 1992-08-12 1992-08-12 New isobutyl-substituted methanesulfonyl-quinolylmethoxyphenyl-cycloalkylacetic acid aminols

Publications (4)

Publication Number Publication Date
NO932731D0 NO932731D0 (en) 1993-07-29
NO932731L true NO932731L (en) 1994-02-14
NO179948B NO179948B (en) 1996-10-07
NO179948C NO179948C (en) 1997-01-15

Family

ID=6465373

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932731A NO179948C (en) 1992-08-12 1993-07-29 New isobutyl-substituted methanesulfonyl-quinolylmethoxyphenyl-cycloalkylacetic acid amides and their use

Country Status (19)

Country Link
EP (1) EP0582916A1 (en)
JP (1) JPH06157462A (en)
KR (1) KR940003937A (en)
CN (1) CN1039998C (en)
AU (1) AU669913B2 (en)
CA (1) CA2103600A1 (en)
CZ (1) CZ282341B6 (en)
DE (1) DE4226649A1 (en)
FI (1) FI933529A (en)
HU (1) HUT70171A (en)
IL (1) IL106623A0 (en)
MX (1) MX9304608A (en)
MY (1) MY108716A (en)
NO (1) NO179948C (en)
NZ (1) NZ248350A (en)
PL (1) PL174102B1 (en)
RU (1) RU2103261C1 (en)
SK (1) SK86693A3 (en)
ZA (1) ZA935828B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443891A1 (en) 1994-12-09 1996-06-13 Bayer Ag Heterocyclically substituted oxy-phenyl- (phenyl) glycinolamides
DE4443892A1 (en) * 1994-12-09 1996-06-13 Bayer Ag 4- (Quinolin-2-yl-methoxy) phenyl acetic acid derivatives
US5931170A (en) * 1998-10-08 1999-08-03 Addway Engineering Limited Dental flosser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (en) * 1988-04-29 1989-11-09 Bayer Ag (ALPHA) -SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC ACIDS AND SITES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICAMENTS
DE3900261A1 (en) * 1988-05-31 1989-12-07 Bayer Ag SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL-ACETIC ACID DERIVATIVES
DE3916663A1 (en) * 1989-05-23 1990-11-29 Bayer Ag SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL-ACYL-SULPHONAMIDES AND CYANAMIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
DE4105551A1 (en) * 1991-02-22 1992-08-27 Bayer Ag 2-SUBSTITUTED CHINOLINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DE4112533A1 (en) * 1991-04-17 1992-10-22 Bayer Ag METHOD FOR THE PRODUCTION OF ENANTIOMER-PURE SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC ACIDS

Also Published As

Publication number Publication date
FI933529A (en) 1994-02-13
IL106623A0 (en) 1993-12-08
NZ248350A (en) 1994-12-22
MX9304608A (en) 1994-02-28
NO179948C (en) 1997-01-15
NO932731D0 (en) 1993-07-29
CZ163693A3 (en) 1994-03-16
MY108716A (en) 1996-11-30
SK86693A3 (en) 1994-09-07
ZA935828B (en) 1994-03-10
AU669913B2 (en) 1996-06-27
PL300025A1 (en) 1994-03-21
PL174102B1 (en) 1998-06-30
FI933529A0 (en) 1993-08-10
CN1039998C (en) 1998-09-30
CA2103600A1 (en) 1994-02-13
NO179948B (en) 1996-10-07
RU2103261C1 (en) 1998-01-27
AU4425593A (en) 1994-02-17
EP0582916A1 (en) 1994-02-16
HU9302320D0 (en) 1993-10-28
HUT70171A (en) 1995-09-28
KR940003937A (en) 1994-03-14
JPH06157462A (en) 1994-06-03
DE4226649A1 (en) 1994-02-17
CN1087084A (en) 1994-05-25
CZ282341B6 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
NO930193D0 (en) BIARLYL SUBSTITUTED 4-AMINO ACID ACID AMIDES
NO921105D0 (en) NEW CARBOXYLIC ACID AMIDES
NO974646L (en) New connections
NO924978L (en) CHINOLON AND NAFTYRIDON CARBOXYLIC ACID DERIVATIVES
NO932665D0 (en) NEW CARBOHYDRATE-BASED ANTI-INFLAMMATORY AGENTS
NO930760L (en) SUBSTITUTED PHENYLEDIC DIETIC ACID AMIDES
PT807102E (en) ALCOHOL-ACETIC ACID AMIDES
DE59402189D1 (en) 2-keto-3-methyl-4-hydroxy-valeric acid
NO930722L (en) IMIDAZOLYL-SUBSTITUTED PHENYLEDIC DIETIC ACID AMIDES
DE59305938D1 (en) Pyridyloxy-acrylic acid ester
NO934426D0 (en) New amidoalkyl and imidoalkylpiperines
DE69326794D1 (en) Reversible electrode
DE59301060D1 (en) Substituted amino acid amides.
DE69317893D1 (en) Percarboxylic acid
NO932003D0 (en) NEW TIOSEMIC CARBON ZONES
NO922243L (en) NEW CEFEM CONNECTIONS
NO924465L (en) KINOLYLMETOKSYFENYL-acetic acid amide
NO932731L (en) New isobutyl-substituted methanesulfonyl-quinolylmethoxy-phenyl-cycloalkyl-acetic acid amides
DE69320499D1 (en) Anesthesia monitoring
NO930067D0 (en) NEW CHEMICAL COMPOUNDS
NO940195L (en) New connections
NO932002D0 (en) NEW TIOSEMIC CARBONOIC ACID ESTERS
NO924900D0 (en) NEW TIAZOLS
NO954913D0 (en) New heterocyclic amides
NO942051D0 (en) New thiosemicarbazontions